TrueBlue, Inc. 10-Q Summary: Q2 2024
Business Context and Reporting Period
This summary covers the quarterly report (Form 10-Q) for TrueBlue, Inc. for the period ended June 30, 2024. TrueBlue is a leading provider of specialized workforce solutions operating through three reportable segments: PeopleReady (contingent staffing), PeopleScout (recruitment process outsourcing and managed service provider), and PeopleManagement (on-site workforce management and commercial driving). The company operates in a cyclical environment heavily influenced by economic conditions and labor market trends.
Key Financial Metrics
| Metric | Q2 2024 (13 weeks) | Q2 2023 (13 weeks) | YTD 2024 (26 weeks) | YTD 2023 (26 weeks) |
|---|---|---|---|---|
| Revenue | $396.2 million | $475.6 million | $799.1 million | $940.9 million |
| Gross Profit | $104.4 million | $130.5 million | $203.8 million | $253.6 million |
| Gross Margin | 26.4% | 27.4% | 25.5% | 27.0% |
| Operating Income (Loss) | $(59.96) million | $(6.56) million | $(75.47) million | $(12.50) million |
| Net Income (Loss) | $(104.71) million | $(7.32) million | $(106.41) million | $(11.61) million |
| Diluted EPS | $(3.45) | $(0.24) | $(3.46) | $(0.37) |
| Cash & Equivalents | $26.4 million | See Liquidity Section | ||
| Debt Outstanding | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 16.7% year-over-year in Q2 and 15.1% year-over-year YTD. All three segments experienced declines: PeopleReady (-18.9%), PeopleScout (-31.2%), and PeopleManagement (-6.3%). Management attributes this to economic uncertainty, inflation, and clients reducing contingent labor and hiring volumes.
- Impairment Charges: The company recorded a significant non-cash goodwill and intangible asset impairment charge of $59.7 million in Q2. This includes a $59.1 million charge fully impairing the goodwill of the PeopleReady reporting unit and a $0.6 million charge for a PeopleManagement trade name. These were triggered by declining demand and a decrease in stock price.
- Tax Provision: Income tax expense increased significantly to $46.5 million in Q2 (vs. $1.3 million prior year) due to the recording of a full valuation allowance against U.S. federal and state deferred tax assets. This was driven by cumulative pre-tax losses and the non-deductible goodwill impairment charge.
- Divestiture: The company completed the sale of PeopleReady Canada in February 2024, recognizing a pre-tax gain of $0.7 million.
- Government Subsidies: The company recognized a net benefit of $6.8 million related to COVID-19 government subsidies in Q2, partially offsetting operating expenses.
Guidance, Outlook, and Risks
- Q3 2024 Outlook:
- Revenue: Expected to decline between 14% and 20% compared to Q3 2023.
- Gross Margin: Expected to decline 20 to 60 basis points year-over-year due to business mix changes.
- SG&A Expense: Anticipated to be between $99 million and $103 million.
- Effective Tax Rate: Expected to be between (35)% and (40)% for the full fiscal year 2024 due to the valuation allowance.
- Liquidity: As of June 30, 2024, the company held $26.4 million in cash and cash equivalents with no debt. It has a $255 million revolving credit facility with $132.5 million available for borrowing (constrained by covenants).
- Risks:
- Economic Sensitivity: Continued uncertainty regarding interest rates and inflation is driving reduced client demand.
- Workers' Compensation: The company is substantially self-insured. Collateral requirements may increase based on loss history and market dynamics.
- Valuation Allowance: The full valuation allowance on deferred tax assets limits the ability to utilize tax credits and losses in the near term.
Investor Verification Checklist
- Verify the sustainability of the 16.7% revenue decline across all segments and the specific impact of the renewable energy sector on PeopleReady margins.
- Confirm the full valuation allowance on deferred tax assets and its impact on future effective tax rates and cash tax payments.
- Review the goodwill impairment details for PeopleReady to understand the revised fair value assumptions and recovery timeline.
- Monitor workers' compensation collateral requirements and the potential for increased restricted cash needs.
- Assess the company's ability to meet Q3 revenue guidance given the continued macroeconomic headwinds.